Ali Yurtseven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ali Yurtseven has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Caner Turan
Division of Pediatric Emergency Medicine, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey
9 shared publications- Caner Turan
Department of Pediatrics, Division of Emergency Medicine, Ege University Faculty of Medicine, Izmir, Turkey
9 shared publications - Eylem Ulaş Saz
Ege Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Acil Bilim Dalı, İzmir
8 shared publications - Eylem Ulas Saz
Department of Pediatrics, Pediatric Emergency Care, Ege University Faculty of Medicine, Izmir, Turkey
6 shared publications Eylem Ulas Saz
Division of Pediatric Emergency Medicine, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey
5 shared publicationsEylem Ulaş Saz
Department of Pediatrics, Faculty of Medicine, Ege University, Bornova, Izmir, Turkey
5 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1)
Clinical characteristics and outcomes of pediatric methylphenidate intoxication: a five-year single-center study
Methylphenidate is widely prescribed for attention-deficit/hyperactivity disorder, and its use has increased substantially in recent years. Although generally considered safe within therapeutic ranges, supratherapeutic ingestion may result in various systemic adverse effects. This study aimed to evaluate the demographic and clinical characteristics of children presenting with overdose ingestion and to identify potential factors associated with symptom development. We conducted a retrospective review of patients younger than 18 years who presented to a tertiary pediatric emergency department between January 1, 2020, and December 31, 2024, due to overdose ingestion. Demographic characteristics, psychiatric history, ingested dose, mode of exposure, clinical findings, emergency department course, and factors potentially associated with adverse effects were analyzed. Thirty-two patients were included; 72% were female, and ingestion was intentional in 84%. The mean ingested dose was 5.7 mg/kg. Clinical symptoms developed in 41% of patients. The most frequent findings were tachycardia (38%), mild hypertension (34%), agitation (22%), and seizures (16%). Although most cases were mild and resolved within 12 h of observation, one toddler developed neuropsychiatric manifestations requiring close monitoring with full recovery within 48 h. No statistically significant association was observed between age, sex, gastrointestinal decontamination status, or reported ingested dose and the development of clinical symptoms (p > 0.05). Pediatric methylphenidate intoxication is generally mild, but severe neuropsychiatric and cardiovascular effects may occur. Careful clinical monitoring remains essential. Not applicable.
- 26 June 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1)
Open AccessClinical characteristics and outcomes of pediatric methylphenidate intoxication: a five-year single-center study
Methylphenidate is widely prescribed for attention-deficit/hyperactivity disorder, and its use has increased substantially in recent years. Although generally considered safe within therapeutic ranges, supratherapeutic ingestion may result in various systemic adverse effects. This study aimed to evaluate the demographic and clinical characteristics of children presenting with overdose ingestion and to identify potential factors associated with symptom development. We conducted a retrospective review of patients younger than 18 years who presented to a tertiary pediatric emergency department between January 1, 2020, and December 31, 2024, due to overdose ingestion. Demographic characteristics, psychiatric history, ingested dose, mode of exposure, clinical findings, emergency department course, and factors potentially associated with adverse effects were analyzed. Thirty-two patients were included; 72% were female, and ingestion was intentional in 84%. The mean ingested dose was 5.7 mg/kg. Clinical symptoms developed in 41% of patients. The most frequent findings were tachycardia (38%), mild hypertension (34%), agitation (22%), and seizures (16%). Although most cases were mild and resolved within 12 h of observation, one toddler developed neuropsychiatric manifestations requiring close monitoring with full recovery within 48 h. No statistically significant association was observed between age, sex, gastrointestinal decontamination status, or reported ingested dose and the development of clinical symptoms (p > 0.05). Pediatric methylphenidate intoxication is generally mild, but severe neuropsychiatric and cardiovascular effects may occur. Careful clinical monitoring remains essential. Not applicable.
- Open Access
- 20 January 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (2) , 92
A comparative evaluation of salivary and serum procalcitonin to identify infants with serious bacterial infections
Differentiating serious bacterial infections (SBIs) from viral illnesses in infants remains challenging. Although serum procalcitonin (PCT) is a well-established biomarker, its measurement requires invasive blood sampling. This study investigated the correlation between salivary and serum PCT and evaluated the diagnostic accuracy of salivary PCT for identifying SBIs in infants under 1 year of age. This prospective observational study included 160 infants under one 1 year of age presenting to a pediatric emergency department with suspected SBI. Paired serum and saliva samples were collected. Salivary PCT and serum PCT levels were measured. Serum C-reactive protein (CRP), a routinely used inflammatory marker in pediatric emergency practice, was included as a comparator biomarker. Patients were classified into SBI and viral infection groups based on final diagnoses. The diagnostic accuracy of the biomarkers was assessed and compared using receiver operating characteristic (ROC) curve analysis.Of the 160 infants (median age 8 months; 63% male), 11.3% ( n = 18) were diagnosed with SBI and 88.7% ( n = 142) with viral infections. Median salivary PCT levels were markedly higher in the SBI group than in the viral infection group (69.3 pg/mL vs. p < 0.001). The area under the curve (AUC) for diagnosing SBI was 0.92 for salivary PCT, 0.96 for serum PCT, and 0.88 for serum CRP. At a cutoff value of 31.3 pg/mL, salivary PCT demonstrated a sensitivity of 89% and a specificity of 92.3%, with a negative predictive value (NPV) of 98.7%. A weak but statistically significant correlation was found between serum and salivary PCT levels (r = 0.250; p = 0.001). Conclusion: Salivary PCT shows strong correlation with serum PCT and demonstrates high diagnostic accuracy as a non-invasive biomarker for identifying SBIs in infants. Its performance approaches that of serum PCT and exceeds that of serum CRP, highlighting its potential clinical value in reducing the need for invasive blood sampling. What is Known: • Serum procalcitonin (PCT) is a well-established marker for detecting serious bacterial infections (SBI) in infants, surpassing CRP, though it requires invasive sampling. What is New: • Salivary PCT demonstrates comparable diagnostic performance to serum PCT and exceeds CRP, highlighting its potential as a non-invasive alternative for SBI assessment in infants.
- 20 January 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (2) , 92
Open AccessA comparative evaluation of salivary and serum procalcitonin to identify infants with serious bacterial infections
Differentiating serious bacterial infections (SBIs) from viral illnesses in infants remains challenging. Although serum procalcitonin (PCT) is a well-established biomarker, its measurement requires invasive blood sampling. This study investigated the correlation between salivary and serum PCT and evaluated the diagnostic accuracy of salivary PCT for identifying SBIs in infants under 1 year of age. This prospective observational study included 160 infants under one 1 year of age presenting to a pediatric emergency department with suspected SBI. Paired serum and saliva samples were collected. Salivary PCT and serum PCT levels were measured. Serum C-reactive protein (CRP), a routinely used inflammatory marker in pediatric emergency practice, was included as a comparator biomarker. Patients were classified into SBI and viral infection groups based on final diagnoses. The diagnostic accuracy of the biomarkers was assessed and compared using receiver operating characteristic (ROC) curve analysis.Of the 160 infants (median age 8 months; 63% male), 11.3% ( n = 18) were diagnosed with SBI and 88.7% ( n = 142) with viral infections. Median salivary PCT levels were markedly higher in the SBI group than in the viral infection group (69.3 pg/mL vs. p < 0.001). The area under the curve (AUC) for diagnosing SBI was 0.92 for salivary PCT, 0.96 for serum PCT, and 0.88 for serum CRP. At a cutoff value of 31.3 pg/mL, salivary PCT demonstrated a sensitivity of 89% and a specificity of 92.3%, with a negative predictive value (NPV) of 98.7%. A weak but statistically significant correlation was found between serum and salivary PCT levels (r = 0.250; p = 0.001). Conclusion: Salivary PCT shows strong correlation with serum PCT and demonstrates high diagnostic accuracy as a non-invasive biomarker for identifying SBIs in infants. Its performance approaches that of serum PCT and exceeds that of serum CRP, highlighting its potential clinical value in reducing the need for invasive blood sampling. What is Known: • Serum procalcitonin (PCT) is a well-established marker for detecting serious bacterial infections (SBI) in infants, surpassing CRP, though it requires invasive sampling. What is New: • Salivary PCT demonstrates comparable diagnostic performance to serum PCT and exceeds CRP, highlighting its potential as a non-invasive alternative for SBI assessment in infants.
- Open Access
- 25 November 2025
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 41 (12) , 3498-3502
Correlation between single nucleotide polymorphisms in TLR4, LTA and RFP175 genes and susceptibility to invasive bacterial infections in infants under three months of age: A case control study
Objective: This study investigates the correlation of TLR4 rs2149356, LTA rs2229094 and RFP175 rs1585110 genes single nucleotide polymorphisms (SNPs) with invasive bacterial infections (IBIs) in neonates and young infants. Methodology: We conducted a prospective, case-control study at Ege University Faculty of Medicine, Izmir, Turkiye, between January 2021 to December 2023. Infants under 90 days of age admitted with confirmed IBIs (cases) or non-infectious conditions (controls) were included. Genomic DNA was extracted from peripheral blood samples and next-generation sequencing was used to analyze selected SNPs in TLR4, LTA and RFP175 genes. Clinical and demographic characteristics, as well as SNP frequencies, were compared between groups. Results: A total of 200 infants were enrolled (100 cases, 100 controls). Most infections were urinary tract infections (n=84), with smaller numbers of gastroenteritis (n=6), bacteremia (n=5), pneumonia (n=3) and meningitis (n=2). No significant differences were found in clinical characteristics or SNP frequencies between groups. Conclusions: This study found no association between the investigated SNPs in TLR4, LTA and RFP175 and susceptibility to IBIs in infants under three months. Larger studies are needed to clarify the genetic contribution to early-life infections.
- 25 November 2025
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 41 (12) , 3498-3502
Open AccessCorrelation between single nucleotide polymorphisms in TLR4, LTA and RFP175 genes and susceptibility to invasive bacterial infections in infants under three months of age: A case control study
Objective: This study investigates the correlation of TLR4 rs2149356, LTA rs2229094 and RFP175 rs1585110 genes single nucleotide polymorphisms (SNPs) with invasive bacterial infections (IBIs) in neonates and young infants. Methodology: We conducted a prospective, case-control study at Ege University Faculty of Medicine, Izmir, Turkiye, between January 2021 to December 2023. Infants under 90 days of age admitted with confirmed IBIs (cases) or non-infectious conditions (controls) were included. Genomic DNA was extracted from peripheral blood samples and next-generation sequencing was used to analyze selected SNPs in TLR4, LTA and RFP175 genes. Clinical and demographic characteristics, as well as SNP frequencies, were compared between groups. Results: A total of 200 infants were enrolled (100 cases, 100 controls). Most infections were urinary tract infections (n=84), with smaller numbers of gastroenteritis (n=6), bacteremia (n=5), pneumonia (n=3) and meningitis (n=2). No significant differences were found in clinical characteristics or SNP frequencies between groups. Conclusions: This study found no association between the investigated SNPs in TLR4, LTA and RFP175 and susceptibility to IBIs in infants under three months. Larger studies are needed to clarify the genetic contribution to early-life infections.
- Open Access
- 14 February 2025
- Published by Quality in Medicine, Education & Library in Journal of Immunology and Clinical Microbiology
- Vol. 9 (4) , 109-117
The Impact of Genetic Variants of Angiotensin-converting enzymes (ACE1, ACE2) On the Severity of COVID-19 Disease
Objective: This study aimed to explore whether there is a potential link between ACE1 I/D and ACE2 rs2285666 polymorphisms and COVID-19 severity. Methods: A prospective observational study was conducted involving 200 patients who were diagnosed with COVID-19 through polymerase chain reaction testing. Demographic and clinical data were collected, and genetic analyses of ACE1 I/D and ACE2 rs2285666 genes were carried out using next-generation sequencing. Patients were classified into three groups based on disease severity: mild, moderate, and severe. Results: The average age of participants was 52 (±27) years, with 116 (58%) being male. Among them, 120 (60%) had at least one chronic illness, and one-fourth were smokers. Fifty-two (26%) patients with severe symptoms required intensive care, and 19 (9.5%) of these individuals unfortunately passed away. Meanwhile, the remaining 74% with mild or moderate symptoms were discharged after recovering. No statistically significant association was found between ACE1 I/D and ACE2 rs2285666 polymorphisms and COVID-19 severity or mortality. Conclusion: The results indicate that ACE1 I/D and ACE2 rs2285666 polymorphisms do not significantly impact the severity of COVID-19. Further studies including diverse ethnic groups and examining other polymorphisms are needed to provide a more comprehensive understanding of these genetic influences.
- 14 February 2025
- Published by Quality in Medicine, Education & Library in Journal of Immunology and Clinical Microbiology
- Vol. 9 (4) , 109-117
Open AccessThe Impact of Genetic Variants of Angiotensin-converting enzymes (ACE1, ACE2) On the Severity of COVID-19 Disease
Objective: This study aimed to explore whether there is a potential link between ACE1 I/D and ACE2 rs2285666 polymorphisms and COVID-19 severity. Methods: A prospective observational study was conducted involving 200 patients who were diagnosed with COVID-19 through polymerase chain reaction testing. Demographic and clinical data were collected, and genetic analyses of ACE1 I/D and ACE2 rs2285666 genes were carried out using next-generation sequencing. Patients were classified into three groups based on disease severity: mild, moderate, and severe. Results: The average age of participants was 52 (±27) years, with 116 (58%) being male. Among them, 120 (60%) had at least one chronic illness, and one-fourth were smokers. Fifty-two (26%) patients with severe symptoms required intensive care, and 19 (9.5%) of these individuals unfortunately passed away. Meanwhile, the remaining 74% with mild or moderate symptoms were discharged after recovering. No statistically significant association was found between ACE1 I/D and ACE2 rs2285666 polymorphisms and COVID-19 severity or mortality. Conclusion: The results indicate that ACE1 I/D and ACE2 rs2285666 polymorphisms do not significantly impact the severity of COVID-19. Further studies including diverse ethnic groups and examining other polymorphisms are needed to provide a more comprehensive understanding of these genetic influences.
- Open Access
- 6 May 2024
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 38 (9) , e25040
The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock
Background: Despite advancements in antibiotic therapy and resuscitation protocols, sepsis and septic shock remain major contributors to morbidity and mortality in children. We aimed to investigate the utility of soluble urokinase plasminogen activator receptor (suPAR) for the early detection of septic shock and to evaluate its accuracy in predicting mortality.Methods: A prospective study was conducted in a tertiary pediatric emergency department (ED), enrolling patients diagnosed with the sepsis, severe sepsis, or septic shock. In addition to assessing infection biomarkers such as C‐reactive protein and procalcitonin, suPAR levels were quantified upon admission using enzyme‐linked immunosorbent assay. The primary outcome measure was 30‐day mortality.Results: Overall 72 patients and 80 healthy children included. Plasma suPAR levels demonstrated a statistically significant elevation in the sepsis, severe sepsis, and septic shock groups compared with the control group (p < 0.001 for all). The septic shock group exhibited the highest suPAR levels upon admission, surpassing both the sepsis and severe sepsis groups (p = 0.009 and 0.042). ROC analysis underscored the promising potential of suPAR with an AUC of 0.832 for septic shock. Analysis of mortality prediction revealed significantly higher suPAR levels in nonsurvivors than survivors (9.7 ng/mL vs. 4.2 ng/mL; p < 0.001). Employing plasma suPAR levels to discriminate between mortality and survival, a threshold of ≥7.0 ng/mL demonstrated a sensitivity of 90.9% and specificity of 71.0%.Conclusion: Plasma suPAR levels have the potential as a biomarker for predicting mortality in children with septic shock. In pediatric septic shock, the presence of plasma suPAR ≥7 ng/mL along with an underlying disease significantly increases the risk of mortality.
- 6 May 2024
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 38 (9) , e25040
Open AccessThe Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock
Background: Despite advancements in antibiotic therapy and resuscitation protocols, sepsis and septic shock remain major contributors to morbidity and mortality in children. We aimed to investigate the utility of soluble urokinase plasminogen activator receptor (suPAR) for the early detection of septic shock and to evaluate its accuracy in predicting mortality.Methods: A prospective study was conducted in a tertiary pediatric emergency department (ED), enrolling patients diagnosed with the sepsis, severe sepsis, or septic shock. In addition to assessing infection biomarkers such as C‐reactive protein and procalcitonin, suPAR levels were quantified upon admission using enzyme‐linked immunosorbent assay. The primary outcome measure was 30‐day mortality.Results: Overall 72 patients and 80 healthy children included. Plasma suPAR levels demonstrated a statistically significant elevation in the sepsis, severe sepsis, and septic shock groups compared with the control group (p < 0.001 for all). The septic shock group exhibited the highest suPAR levels upon admission, surpassing both the sepsis and severe sepsis groups (p = 0.009 and 0.042). ROC analysis underscored the promising potential of suPAR with an AUC of 0.832 for septic shock. Analysis of mortality prediction revealed significantly higher suPAR levels in nonsurvivors than survivors (9.7 ng/mL vs. 4.2 ng/mL; p < 0.001). Employing plasma suPAR levels to discriminate between mortality and survival, a threshold of ≥7.0 ng/mL demonstrated a sensitivity of 90.9% and specificity of 71.0%.Conclusion: Plasma suPAR levels have the potential as a biomarker for predicting mortality in children with septic shock. In pediatric septic shock, the presence of plasma suPAR ≥7 ng/mL along with an underlying disease significantly increases the risk of mortality.
- Open Access
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1870-1876
Suicide attempt management among Turkish and American adolescents: A comparison of two pediatric emergency departments
Background/aim: Suicide is one of the leading causes of death among adolescents. This study aimed to compare the characteristics and short-term outcomes of Turkish and American adolescents with suicide attempts and determine the differences in management and resource utilization between two pediatric emergency departments; one in Türkiye and one in the United States of America. Materials and methods: Adolescents who presented to the emergency departments with a chief complaint of suicide attempt between October 2017 and September 2018 were eligible for including in the study. Characteristics and other information of 217 (131 American and 86 Turkish) suicide attempter adolescents were retrieved from medical records. Outcome was defined as re-admission to the emergency department for another suicide attempt within 3 months of the index visit. Results: Overall, 78% of adolescents were female. Abuse history (physical/sexual) was more common among American adolescents (p = 0.005), whereas uncontrolled psychiatric diseases were more evident in Turkish cases (p < 0.001). Social worker assessment and hospitalization rates were significantly lower, with shorter mean duration of follow-up in the emergency department among Turkish compared to American adolescents (respectively, p < 0.001, p < 0.001 and p = 0.002). Repeated suicide attempts within three months were significantly higher in the Turkish group compared to the American one (29% vs. 8%, p < 0.001). Receiving a social worker assessment, hospitalization and longer observation in emergency department reduced the incidence of repeated suicide attempts (respectively, p < 0.001, p = 0.003 and p = 0.012). Conclusion: Turkish adolescents had shorter observation time in the emergency department, received fewer assessment by social workers and were less likely to be hospitalized. These may have contributed to the higher rate of repeat suicide attempts following discharge from the emergency department. Adequate resources are needed to help decrease the burden of suicide among Turkish adolescents.
- 12 December 2023
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1870-1876
Open AccessSuicide attempt management among Turkish and American adolescents: A comparison of two pediatric emergency departments
Background/aim: Suicide is one of the leading causes of death among adolescents. This study aimed to compare the characteristics and short-term outcomes of Turkish and American adolescents with suicide attempts and determine the differences in management and resource utilization between two pediatric emergency departments; one in Türkiye and one in the United States of America. Materials and methods: Adolescents who presented to the emergency departments with a chief complaint of suicide attempt between October 2017 and September 2018 were eligible for including in the study. Characteristics and other information of 217 (131 American and 86 Turkish) suicide attempter adolescents were retrieved from medical records. Outcome was defined as re-admission to the emergency department for another suicide attempt within 3 months of the index visit. Results: Overall, 78% of adolescents were female. Abuse history (physical/sexual) was more common among American adolescents (p = 0.005), whereas uncontrolled psychiatric diseases were more evident in Turkish cases (p < 0.001). Social worker assessment and hospitalization rates were significantly lower, with shorter mean duration of follow-up in the emergency department among Turkish compared to American adolescents (respectively, p < 0.001, p < 0.001 and p = 0.002). Repeated suicide attempts within three months were significantly higher in the Turkish group compared to the American one (29% vs. 8%, p < 0.001). Receiving a social worker assessment, hospitalization and longer observation in emergency department reduced the incidence of repeated suicide attempts (respectively, p < 0.001, p = 0.003 and p = 0.012). Conclusion: Turkish adolescents had shorter observation time in the emergency department, received fewer assessment by social workers and were less likely to be hospitalized. These may have contributed to the higher rate of repeat suicide attempts following discharge from the emergency department. Adequate resources are needed to help decrease the burden of suicide among Turkish adolescents.
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 10 (2) , 104-110
The Comparison of Reported Ingested Paracetamol Dose with Serum Blood Concentrations and Their Relationship with N-Acetylcysteine Administration: A Retrospective Study of 117 Patients
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 10 (2) , 104-110
The Comparison of Reported Ingested Paracetamol Dose with Serum Blood Concentrations and Their Relationship with N-Acetylcysteine Administration: A Retrospective Study of 117 Patients
- Open Access
- 5 December 2022
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 69 (1)
The longitudinal evaluation of COVID-19 in pediatric patients and the impact of delta variant
Pediatric patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) displayed milder symptoms than adults. However, they play an important role in case numbers and virus transmission. Therefore, we aimed to determine the epidemiological features of all pediatric patients infected with SARS-CoV-2 and put forth case numbers longitudinally throughout the delta variant dominant period. A retrospective study was conducted at a university hospital and included patients between 0 and18 years old with a SARS-CoV-2 polymerase chain reaction (PCR) positive result, including inpatients and outpatients. Epidemiological and clinical features were recorded from electronic files, and telephone visits were performed between March 2020 and December 2021. During the study period, 3175 coronavirus disease 2019 (COVID-19) pediatric patients were admitted to our hospital with a mean age of 10.61 ± 4.6 years. Of the 1815 patients who could be interviewed, 85.7% reported at least one symptom. Before the delta variant period, 0–4 years aged children were more commonly infected, while school-aged children and adolescents were more common, and the rate of pediatric cases to all COVID-19 cases increased to 35.8% after the delta variant became dominant. Symptomatic cases were significantly higher before the delta variant (87.8% vs. 84.06%, p = 0.016). The hospitalization rate was higher before the delta variant (p < 0.001), whereas PICU admission showed no statistical difference. The frequency of school-aged children and adolescents raised with the impact of both school openings and the delta variant, and the rate of pediatric cases increased in total COVID-19 patient numbers.
- 5 December 2022
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 69 (1)
Open AccessThe longitudinal evaluation of COVID-19 in pediatric patients and the impact of delta variant
Pediatric patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) displayed milder symptoms than adults. However, they play an important role in case numbers and virus transmission. Therefore, we aimed to determine the epidemiological features of all pediatric patients infected with SARS-CoV-2 and put forth case numbers longitudinally throughout the delta variant dominant period. A retrospective study was conducted at a university hospital and included patients between 0 and18 years old with a SARS-CoV-2 polymerase chain reaction (PCR) positive result, including inpatients and outpatients. Epidemiological and clinical features were recorded from electronic files, and telephone visits were performed between March 2020 and December 2021. During the study period, 3175 coronavirus disease 2019 (COVID-19) pediatric patients were admitted to our hospital with a mean age of 10.61 ± 4.6 years. Of the 1815 patients who could be interviewed, 85.7% reported at least one symptom. Before the delta variant period, 0–4 years aged children were more commonly infected, while school-aged children and adolescents were more common, and the rate of pediatric cases to all COVID-19 cases increased to 35.8% after the delta variant became dominant. Symptomatic cases were significantly higher before the delta variant (87.8% vs. 84.06%, p = 0.016). The hospitalization rate was higher before the delta variant (p < 0.001), whereas PICU admission showed no statistical difference. The frequency of school-aged children and adolescents raised with the impact of both school openings and the delta variant, and the rate of pediatric cases increased in total COVID-19 patient numbers.
- Open Access
- 1 July 2022
- Published by Medknow in Turkish Journal of Emergency Medicine
- Vol. 22 (3) , 143-148
Characteristics of pediatric COVID-19 patients admitted to the emergency department and factors associated with pneumonia
OBJECTIVES: Coronavirus disease 2019 (COVID-19) that causes a respiratory illness, continues to be a global pandemic. In this study, we purpose to identify the features of children with COVID-19 and the factors affecting disease severity. METHODS: This is a retrospective, observational study was conducted on patients who presented with suspicion of COVID-19 from April 1, 2020, to March 31, 2021, at a tertiary care medical center in Turkey. The characteristics of 640 children who were confirmed to have COVID-19 by real-time reverse transcription-polymerase chain reaction were retrieved from medical records. RESULTS: The mean age of the cases was 10 ± 6 years, and 56% of them were male. Seasonal difference did not affect the number of cases. The majority of the cases (n = 501, 78%) were infected by family members. Fever (67%) and cough (38%) were common complaints. The mean duration of fever was 1.9 ± 1.1 days. One-fourth of the cases were asymptomatic, 462 (72%) had mild upper respiratory tract infections, and 18 (3%) had pneumonia. Patients with pneumonia were more likely to have comorbidities and had a longer fever duration (both P < 0.001). Fever, cough, and respiratory distress were more common in patients with pneumonia (P = 0.010, P = 0.023, and P < 0.001, respectively). The mean C-reactive protein (CRP) value of the patients with pneumonia was significantly higher than that of the others (P < 0.001). A total of 70 (11%) complicated patients were hospitalized, 5 of them requiring intensive care admission. All hospitalized patients were discharged with recovery. CONCLUSIONS: Although pediatric COVID-19 patients tended to have a mild disease, some children with comorbidities can still develop a severe illness. CRP value is a useful indicator in the diagnosis of COVID-19 pneumonia. Furthermore, the prevalence rate of COVID-19 did not decrease with hot seasons.
- 1 July 2022
- Published by Medknow in Turkish Journal of Emergency Medicine
- Vol. 22 (3) , 143-148
Open AccessCharacteristics of pediatric COVID-19 patients admitted to the emergency department and factors associated with pneumonia
OBJECTIVES: Coronavirus disease 2019 (COVID-19) that causes a respiratory illness, continues to be a global pandemic. In this study, we purpose to identify the features of children with COVID-19 and the factors affecting disease severity. METHODS: This is a retrospective, observational study was conducted on patients who presented with suspicion of COVID-19 from April 1, 2020, to March 31, 2021, at a tertiary care medical center in Turkey. The characteristics of 640 children who were confirmed to have COVID-19 by real-time reverse transcription-polymerase chain reaction were retrieved from medical records. RESULTS: The mean age of the cases was 10 ± 6 years, and 56% of them were male. Seasonal difference did not affect the number of cases. The majority of the cases (n = 501, 78%) were infected by family members. Fever (67%) and cough (38%) were common complaints. The mean duration of fever was 1.9 ± 1.1 days. One-fourth of the cases were asymptomatic, 462 (72%) had mild upper respiratory tract infections, and 18 (3%) had pneumonia. Patients with pneumonia were more likely to have comorbidities and had a longer fever duration (both P < 0.001). Fever, cough, and respiratory distress were more common in patients with pneumonia (P = 0.010, P = 0.023, and P < 0.001, respectively). The mean C-reactive protein (CRP) value of the patients with pneumonia was significantly higher than that of the others (P < 0.001). A total of 70 (11%) complicated patients were hospitalized, 5 of them requiring intensive care admission. All hospitalized patients were discharged with recovery. CONCLUSIONS: Although pediatric COVID-19 patients tended to have a mild disease, some children with comorbidities can still develop a severe illness. CRP value is a useful indicator in the diagnosis of COVID-19 pneumonia. Furthermore, the prevalence rate of COVID-19 did not decrease with hot seasons.
- 7 February 2022
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 58 (6) , 1022-1027
Benign acute childhood myositis associated with influenza A/B in the paediatric emergency department and the efficacy of early‐onset oseltamivir
Aim: To investigate the association of benign acute childhood myositis (BACM) with respiratory viruses. Also, we aimed to assess the effect of antiviral treatment on the improvement and complications.Methods: This study was conducted at an urban‐academic emergency department during four influenza‐seasons (2016–2019), retrospectively. Demographics, clinical findings, laboratories, metabolic disease analyses and serological features were extracted from the medical records. Treatments, complications and outcomes were also recorded.Results: A total of 114 children were included. The median age was 7.0 (min 1.25–max 17) years and 78.9% were male. The most common symptoms were leg pain (91.2%), anorexia (54.4%), fever (45.6%), sore throat (42.1%) and walking difficulty (32.5%). On admission, the median creatine phosphokinase level was 3332 IU/L (range, 1634–50 185), median aspartate aminotransferase 107 U/L (range, 38–1798). In the multiplex polymerase chain reaction analysis, 40.4% influenza B, 36.8% influenza A, 7.8% adenovirus, 7.8% parainfluenza virus, 5.3% rhinovirus, 5.3% respiratory syncytial virus and 1.8% Mycoplasma pneumoniae were detected. Rhabdomyolysis was developed in 6.7% and acute renal failure was seen in two patients. Oseltamivir was given in 44 (38.6%) patients who had influenza A/B. Metabolic disease screening tests were performed in 33.3% of patients and metabolic diseases were detected in 4 (3.5%) patients. The median recovery time was lower in patients with oseltamivir treatment (4 (min 2–max 5) − 5 (min 3–max 10) days) (P < 0.001).Conclusion: Rhabdomyolysis is more common in BACM due to the influenza A virus. The early use of oseltamivir treatment was significantly associated with a shorter recovery time.
- 7 February 2022
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 58 (6) , 1022-1027
Benign acute childhood myositis associated with influenza A/B in the paediatric emergency department and the efficacy of early‐onset oseltamivir
Aim: To investigate the association of benign acute childhood myositis (BACM) with respiratory viruses. Also, we aimed to assess the effect of antiviral treatment on the improvement and complications.Methods: This study was conducted at an urban‐academic emergency department during four influenza‐seasons (2016–2019), retrospectively. Demographics, clinical findings, laboratories, metabolic disease analyses and serological features were extracted from the medical records. Treatments, complications and outcomes were also recorded.Results: A total of 114 children were included. The median age was 7.0 (min 1.25–max 17) years and 78.9% were male. The most common symptoms were leg pain (91.2%), anorexia (54.4%), fever (45.6%), sore throat (42.1%) and walking difficulty (32.5%). On admission, the median creatine phosphokinase level was 3332 IU/L (range, 1634–50 185), median aspartate aminotransferase 107 U/L (range, 38–1798). In the multiplex polymerase chain reaction analysis, 40.4% influenza B, 36.8% influenza A, 7.8% adenovirus, 7.8% parainfluenza virus, 5.3% rhinovirus, 5.3% respiratory syncytial virus and 1.8% Mycoplasma pneumoniae were detected. Rhabdomyolysis was developed in 6.7% and acute renal failure was seen in two patients. Oseltamivir was given in 44 (38.6%) patients who had influenza A/B. Metabolic disease screening tests were performed in 33.3% of patients and metabolic diseases were detected in 4 (3.5%) patients. The median recovery time was lower in patients with oseltamivir treatment (4 (min 2–max 5) − 5 (min 3–max 10) days) (P < 0.001).Conclusion: Rhabdomyolysis is more common in BACM due to the influenza A virus. The early use of oseltamivir treatment was significantly associated with a shorter recovery time.